VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CLXThe Clorox Company
$97.09$11.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCLXFinancials

The Clorox Company (CLX) Financials

30Y historyFree accessUpdated daily

Revenue growth remains highly volatile with a 2026Q1 contraction of 18.9%, while gross margins have struggled to sustain historical levels, recently declining to 43.2% in 2026Q3.

CLX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97Jun'96
Sales/Revenue6.76B7.1B7.09B7.39B7.11B7.34B6.72B6.21B6.12B5.97B5.76B5.66B5.51B5.62B5.47B5.23B5.23B5.45B5.27B4.85B4.64B4.39B4.32B4.14B4.06B3.9B4.08B4B2.74B2.53B2.22B
Revenue Growth %-3.69%0.16%-4.01%3.97%-3.19%9.22%8.16%1.47%2.53%3.68%1.87%2.56%-1.94%2.83%4.53%-0.06%-3.96%3.36%8.79%4.37%5.83%1.48%4.34%2.04%4.05%-4.41%2%46.03%8.24%14.2%11.77%
Cost of Goods Sold3.8B3.91B4.07B4.52B4.62B4.16B3.67B3.5B3.46B3.31B3.16B3.2B3.17B3.22B3.18B2.97B2.91B3.07B3.08B2.76B2.69B2.5B2.39B2.23B2.31B2.32B2.05B1.78B1.05B997.1M890.7M
COGS % of Revenue-55.04%57.35%61.14%64.95%56.67%54.56%56.37%56.5%55.37%54.83%56.52%57.49%57.26%58.14%56.72%55.52%56.4%58.45%56.96%57.92%56.91%55.2%53.69%56.83%59.42%50.18%44.54%38.48%39.37%40.16%
Gross Profit2.96B3.19B3.02B2.87B2.49B3.18B3.05B2.71B2.66B2.67B2.6B2.46B2.34B2.4B2.29B2.26B2.33B2.38B2.19B2.09B1.95B1.89B1.94B1.92B1.75B1.58B2.03B2.22B1.69B1.54B1.33B
Gross Margin %43.77%44.96%42.65%38.86%35.05%43.33%45.44%43.63%43.5%44.63%45.17%43.48%42.51%42.74%41.86%43.28%44.48%43.6%41.55%43.04%42.08%43.09%44.8%46.31%43.17%40.58%49.82%55.46%61.52%60.63%59.84%
Gross Profit Growth %-5.59%5.36%15.25%-21.69%4.16%12.65%1.76%-0.07%2.46%5.82%4.91%-2.46%4.98%1.1%-2.75%-2.02%8.44%5.03%6.76%3.33%-2.37%0.94%9.47%10.67%-22.12%-8.38%31.64%9.82%15.71%10.97%
Operating Expenses1.88B2.02B2.11B2.04B1.79B1.94B1.79B1.6B1.54B1.54B1.53B1.46B1.38B1.44B1.4B1.35B1.35B1.33B1.29B1.21B1.14B1.07B1.06B1.06B1B974M1.25B1.54B1.15B1.07B912.1M
OpEx % of Revenue-28.36%29.73%27.66%25.26%26.47%26.62%25.81%25.13%25.85%26.63%25.76%25.01%25.56%25.62%25.85%25.72%24.33%24.41%24.96%24.63%24.48%24.63%25.68%24.65%24.96%30.71%38.52%41.89%42.22%41.13%
Selling, General & Admin1.77B1.89B1.98B1.91B1.66B1.79B1.64B1.47B1.41B1.41B1.39B1.32B1.25B1.31B1.28B1.24B1.23B1.21B1.18B1.1B1.04B986M981M988M934M847M990M1.28B954.7M892.3M749.8M
SG&A % of Revenue-26.66%27.96%25.78%23.4%24.44%24.46%23.62%22.98%23.59%24.18%23.36%22.74%23.24%23.41%23.65%23.46%22.24%22.3%22.74%22.5%22.47%22.69%23.84%23%21.7%24.25%31.93%34.83%35.23%33.81%
Research & Development116M121M126M138M132M149M145M136M132M135M141M136M125M130M121M115M119M114M111M108M99M88M84M76M67M67M63M62M56M50.5M45.8M
R&D % of Revenue-1.7%1.78%1.87%1.86%2.03%2.16%2.19%2.16%2.26%2.45%2.4%2.27%2.31%2.21%2.2%2.27%2.09%2.11%2.23%2.13%2.01%1.94%1.83%1.65%1.72%1.54%1.55%2.04%1.99%2.07%
Other Operating Expenses000000000000000000000000060M201M202M137.6M126.4M116.5M
Operating Income1.07B1.18B916M827M696M1.24B1.26B1.11B1.13B1.12B1.07B1B965M966M888M912M982M1.05B904M876M810M817M872M855M752M610M780M678M538.1M466.4M415M
Operating Margin %15.9%16.6%12.91%11.19%9.79%16.86%18.82%17.81%18.37%18.78%18.54%17.72%17.5%17.18%16.24%17.43%18.76%19.27%17.14%18.07%17.44%18.62%20.17%20.63%18.52%15.63%19.1%16.94%19.63%18.42%18.71%
Operating Income Growth %-28.71%10.76%18.82%-43.78%-2.13%14.27%-1.6%0.27%5.06%6.59%3.83%-0.1%8.78%-2.63%-7.13%-6.48%16.15%3.2%8.15%-0.86%-6.31%1.99%13.7%23.28%-21.79%15.04%26%15.37%12.39%15.57%
EBITDA1.3B1.4B1.15B1.06B920M1.45B1.44B1.29B1.29B1.28B1.23B1.17B1.14B1.14B1.05B1.07B1.17B1.23B1.1B1.06B998M991M1.07B1.05B942M835M981M880M675.7M592.8M531.5M
EBITDA Margin %19.25%19.68%16.23%14.39%12.95%19.72%21.48%20.74%21.1%21.51%21.4%20.71%20.69%20.22%19.29%20.53%22.26%22.57%20.8%21.79%21.49%22.58%24.72%25.24%23.2%21.39%24.03%21.98%24.65%23.41%23.97%
EBITDA Growth %-0.46%21.46%8.28%15.54%-36.46%0.28%12.02%-0.23%0.54%4.22%5.29%2.63%0.35%7.77%-1.77%-7.81%-5.28%12.12%3.88%5.81%0.71%-7.3%2.2%11.04%12.81%-14.88%11.48%30.24%13.98%11.53%14.79%
D&A (Non-Cash Add-back)226M219M235M236M224M210M179M182M167M163M165M169M176M171M167M162M183M180M193M180M188M174M197M191M190M225M201M202M137.6M126.4M116.5M
EBIT1.1B1.18B501M341M704M993M1.28B1.11B1.13B1.11B1.06B1.02B983M972M914M686M944M972M861M856M780M808M784M760M760M610M725M670M616M551M415M
Net Interest Income-101M-92M-80M-87M-92M-88M-91M-88M-73M-78M-77M-91M-96M-116M-123M-120M-136M-157M-156M-105M-117M-69M000000000
Interest Income5M9M23M16M5M5M2M3M6M4M5M4M3M3M03M3M4M12M8M10M10M000000000
Interest Expense106M101M103M103M97M93M93M91M79M82M82M95M99M119M123M123M139M161M168M113M127M79M000000000
Other Income/Expense-87M-101M-518M-589M-89M-338M-80M-83M-71M-89M-85M-81M-81M-113M-97M-349M-177M-239M-211M-133M-157M-88M-32M-53M-199M-123M-103M-240M17.9M32.6M-44.6M
Pretax Income988M1.08B398M238M607M900M1.19B1.02B1.05B1.03B983M921M861M853M791M563M925M811M693M743M653M729M840M802M498M487M622M430M472M416M370.4M
Pretax Margin %14.62%15.17%5.61%3.22%8.54%12.26%17.63%16.48%17.21%17.29%17.06%16.29%15.61%15.17%14.47%10.76%17.67%14.88%13.14%15.33%14.06%16.61%19.43%19.35%12.26%12.48%15.23%10.74%17.22%16.43%16.7%
Income Tax218M254M106M77M136M181M246M204M231M330M335M315M299M279M248M276M322M274M232M247M210M214M294M288M176M162M228M184M174M166.6M148.3M
Effective Tax Rate %22.06%23.56%26.63%32.35%22.41%20.11%20.76%19.92%21.92%31.95%34.08%34.2%34.73%32.71%31.35%49.02%34.81%33.79%33.48%33.24%32.16%29.36%35%35.91%35.34%33.26%36.66%42.79%36.86%40.05%40.04%
Net Income756M810M280M149M462M710M939M820M823M701M648M580M558M572M541M557M603M537M461M501M444M1.1B549M493M322M323M394M246M343M300M222.1M
Net Margin %11.18%11.4%3.95%2.02%6.5%9.67%13.97%13.2%13.44%11.74%11.25%10.26%10.12%10.17%9.89%10.65%11.52%9.85%8.74%10.34%9.56%24.98%12.7%11.9%7.93%8.28%9.65%6.15%12.51%11.85%10.01%
Net Income Growth %8.93%189.29%87.92%-67.75%-34.93%-24.39%14.51%-0.36%17.4%8.18%11.72%3.94%-2.45%5.73%-2.87%-7.63%12.29%16.49%-7.98%12.84%-59.49%99.64%11.36%53.11%-0.31%-18.02%60.16%-28.28%14.33%35.07%10.61%
Net Income (Continuing)770M824M292M161M471M719M939M820M823M703M648M606M579M574M543M287M526M537M461M496M443M517M490M461M357M325M394M246M350M300M222.1M
Discontinued Operations00000000000000000005M1M579M000000000
Minority Interest159M161M164M168M173M181M0000000000000000000000000
EPS (Diluted)6.216.522.251.203.735.587.356.326.255.334.924.374.234.304.094.024.243.813.243.262.906.112.562.231.371.351.640.521.650.311.07
EPS Growth %10.79%189.78%87.5%-67.83%-33.15%-24.08%16.3%1.12%17.26%8.33%12.59%3.31%-1.63%5.13%1.74%-5.19%11.29%17.59%-0.61%12.41%-52.54%138.67%14.8%62.77%1.48%-17.68%215.38%-68.48%432.26%-71.03%12.63%
EPS (Basic)-6.562.251.213.755.657.466.426.375.435.014.454.314.374.144.064.283.863.303.312.956.202.592.261.391.371.670.531.650.321.07
Diluted Shares Outstanding121.79M124.29M124.8M124.18M123.91M127.3M127.67M129.79M131.58M131.57M131.72M132.78M131.74M132.97M132.57M138.1M141.53M141.06M142M153.94M153M179.18M214.37M220.69M234.7M239.48M239.61M240M207.57M210.68M206.63M
Basic Shares Outstanding121.36M123.53M124.17M123.59M123.11M125.57M125.83M127.73M129.29M128.95M129.47M130.31M129.56M131.07M132.57M136.7M140.27M139.01M139.63M151.44M150.54M176.59M211.68M218.17M231.85M236.15M236.11M235.36M207.57M206.63M206.63M
Dividend Payout Ratio-74.32%212.5%391.28%123.59%78.59%56.76%59.76%54.68%58.77%61.42%66.38%65.95%58.57%58.23%54.4%46.77%48.04%49.46%36.53%38.96%18.34%41.71%39.15%60.87%61.61%47.97%65.85%42.86%44%49.71%

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Volume and pricing volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Growth Remains Highly Volatile

As indicated by the most recent quarterly data, Clorox's top-line performance has fluctuated significantly, with revenue growth rates swinging from a 27.1% expansion in 2025Q1 to an 18.9% contraction in 2026Q1, highlighting the instability inherent in the company's current post-cyberattack recovery and demand environment.

The erratic revenue trajectory suggests that the company is struggling to establish a consistent baseline following the 2023 cybersecurity incident and subsequent supply chain disruptions. Investors should monitor whether the recent stabilization near 0.1% growth in 2026Q3 represents a sustainable floor or merely a pause in a broader period of top-line stagnation.

Gross Margin Recovery Faces Headwinds

Based on reported financial statements, gross margins have struggled to maintain the 46% threshold, recently hovering near 43.2% in 2026Q3, which suggests that inflationary pressures on raw materials like resin continue to challenge the company's ability to sustain its historical premium pricing power.

The compression from the 46.3% peak observed in 2025Q4 indicates that Clorox remains vulnerable to commodity cost volatility despite its strong brand positioning. This margin sensitivity warrants further investigation into whether the company can successfully pass through future cost increases without triggering further volume declines in its core categories.

Operating Leverage Remains Under Pressure

According to the income statement data, operating income has failed to scale consistently with gross profit, as evidenced by the 2026Q3 operating margin of 17.3% compared to the 21.2% achieved in 2025Q4, reflecting persistent inefficiencies in managing overhead costs relative to revenue generation.

The inability to consistently expand operating margins suggests that SG&A expenses remain sticky, potentially limiting the company's ability to translate gross profit gains into bottom-line growth. This lack of operating leverage may indicate that the company is currently prioritizing defensive spending over structural cost optimization.

Sustainability of Earnings Quality Questioned

As reported in recent filings, the volatility in net income, which included a net loss in 2024Q3, combined with inconsistent stock-based compensation charges, suggests that the quality of reported earnings may be lower than the headline EPS figures imply for the casual observer.

Short-term fluctuations in net income, exacerbated by one-time items and varying tax impacts, make it difficult to ascertain the true underlying earnings power of the business. Investors should be wary of relying on EPS growth metrics that may be distorted by non-operating adjustments and the ongoing recovery from operational disruptions.

CLX — Frequently Asked Questions

Quick answers to the most common questions about buying CLX stock.

What was The Clorox Company's (CLX) revenue in 2025?

For fiscal year 2025, The Clorox Company (CLX) reported total revenue of $7.10B. This represents a 220.3% increase compared to $2.22B in 1996.

Is The Clorox Company (CLX) profitable?

The Clorox Company (CLX) is profitable, generating $810.0M in net income for the fiscal year ending 2025 with a net profit margin of 11.4%.

What is The Clorox Company's operating profit margin?

The Clorox Company (CLX) reported an operating income of $1.18B, resulting in an operating profit margin of 16.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is The Clorox Company's gross profit and gross margin?

The Clorox Company (CLX) generated $3.19B in gross profit for the year, representing a gross profit margin of 45.0%. This demonstrates the company's core pricing power and production efficiency.